SCHEMBL19473737

SCHEMBL19473737

O=C(Nc1ccc(Br)cc1)NC1CCCCC1C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.64
NPC1 O15118 2/20 0.64
KMT2A Q03164 2/20 0.64
EPHX1 P07099 2/20 0.64
MEN1 O00255 1/20 0.64
CHRNA7 P36544 1/20 0.57
FPR2 P25090 4/20 0.50
FPR1 P21462 1/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
FPR3 P25089 1/20 0.49
HTT P42858 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
POLB P06746 1/20 0.48
EPHX2 P34913 1/20 0.48
HCRTR1 O43613 1/20 0.47
HCRTR2 O43614 1/20 0.47
GRK2 P25098 1/20 0.47
CASP6 P55212 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23509616 1.00 RAB9A (0.64) RAB9ANPC1KMT2AEPHX1MEN1
SCHEMBL19473756 1.00 RAB9A (0.64) RAB9ANPC1KMT2AEPHX1MEN1
SCHEMBL19473738 0.99 RAB9A (0.67) RAB9ANPC1KMT2AEPHX1MEN1
SCHEMBL23509611 0.99 RAB9A (0.67) RAB9ANPC1KMT2AEPHX1MEN1
SCHEMBL19473762 0.97 KMT2A (0.60) RAB9ANPC1KMT2AEPHX1MEN1
SCHEMBL19473763 0.85 EPHX1 (0.51) RAB9ANPC1KMT2AEPHX1MEN1
SCHEMBL5950145 0.83 GRK2 (0.70) RAB9ANPC1KMT2AEPHX1MEN1
SCHEMBL85562 0.82 RAB9A (0.62) RAB9ANPC1KMT2AEPHX1MEN1
SCHEMBL76526 0.82 RAB9A (0.62) RAB9ANPC1KMT2AEPHX1MEN1
SCHEMBL19473764 0.81 RAB9A (0.50) RAB9ANPC1KMT2AEPHX1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11286234-B2 Phenyl urea derivatives as N-formyl peptide receptor modulators ALLERGAN, INC. (US) 2022-03-29 US disclosed
US-20210179550-A1 PHENYL UREA DERIVATIVES AS N-FORMYL PEPTIDE RECEPTOR MODULATORS ALLERGAN, INC. 2021-06-17 US disclosed
WO-2017180323-A1 PHENYL UREA DERIVATIVES AS N-FORMYL PEPTIDE RECEPTOR MODULATORS ALLERGAN, INC. (US) 2017-10-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11286234-B2 Phenyl urea derivatives as N-formyl peptide receptor modulators FPR1, FPR2, FPR3 RAB9A 4635/4885NPC1 2028/4885KMT2A 4689/4885
US-20210179550-A1 PHENYL UREA DERIVATIVES AS N-FORMYL PEPTIDE RECEPTOR MODULATORS FPR1, FPR2, FPR3 RAB9A 4635/4885NPC1 2028/4885KMT2A 4689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.